Cargando…
The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis
Immunotherapy shows promising therapeutic efficacy against various types of cancer, but most fail to respond. Preclinical studies have suggested that concomitant medications, such as statins, non-steroidal anti-inflammatory drugs (NSAIDs), aspirin, metformin and beta-blockers, might affect clinical...
Autores principales: | Zhang, Yongchao, Chen, Hualei, Chen, Shanshan, Li, Zhen, Chen, Jinglong, Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8331004/ https://www.ncbi.nlm.nih.gov/pubmed/34377596 http://dx.doi.org/10.1080/2162402X.2021.1957605 |
Ejemplares similares
-
3437 Associations of aspirin, non-aspirin NSAIDs, statins, and metformin with risk of biliary cancer: A Swedish population-based cohort study
por: Bonilla, Lorena Marcano, et al.
Publicado: (2019) -
Role of aspirin, beta-blocker, statins, and heparin therapy in septic patients under mechanical ventilation: a narrative review
por: Al-Husinat, Lou'i, et al.
Publicado: (2023) -
A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer
por: Zhang, Yongchao, et al.
Publicado: (2022) -
Associations of aspirin, statins and metformin with lung cancer risk and related mortality
por: Frille, Armin, et al.
Publicado: (2021) -
Chemopreventive Effects of Concomitant or Individual Use of Statins, Aspirin, Metformin, and Angiotensin Drugs: A Study Using Claims Data of 23 Million Individuals
por: Wang, Ching-Huan, et al.
Publicado: (2022)